|
May 29
|
Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day
|
|
May 28
|
TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate
|
|
May 28
|
Billionaire Stanley Druckenmiller Just Sold One of Wall Street's Hottest Stock-Split Stocks and Is Piling Into a Promising Drugmaker Instead
|
|
May 28
|
Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Fast Track for Celiac Disease Drug TEV-53408
|
|
May 27
|
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
|
|
May 27
|
Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
|
|
May 27
|
Why Is Teva Stock Trading Higher On Tuesday?
|
|
May 27
|
TEVA Stock Up Around 13% in a Month: Buy, Sell or Hold the Stock?
|
|
May 27
|
Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
|
|
May 26
|
Regulatory Shake-Up Led to the Sell Off in Teva Pharmaceutical Industries Limited (TEVA)
|
|
May 22
|
Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes
|
|
May 19
|
Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031
|
|
May 19
|
Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes
|
|
May 15
|
Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
|
|
May 15
|
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
|
|
May 15
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
May 14
|
Teva Pharmaceutical Industries Limited (TEVA): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying
|
|
May 13
|
Teva's 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy
|
|
Apr 16
|
Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals
|
|
Apr 15
|
3 Generic Drug Stocks to Watch Amid Trade War Jitters & Inflation Woes
|